Amer Zeidan, Professor of Medicine, Chief of Hematologic Malignancies, Director of Heme Clinical Research at Yale University, shared a post on X about a recent article he and his colleagues co-authored, adding:
“Glad to share our tour-de-force review of MDSsm published in Nature Reviews of Clinical Oncology, which has to be the most comprehensive review we have ever written on the subject covering all relevant areas from epidemiology, pathogenesis, diagnosis, risk stratification, to current and evolving therapies for lower and higher risk disease.”
Title: 26 update on myelodysplastic neoplasms: current state, challenges and future directions
Authors: Jan Philipp Bewersdorf, Alain Mina, Maximilian Stahl, Amer M. Zeidan
Read the Full Article on Nature Reviews of Clinical Oncology.
More posts featuring Amer Zeidan.